banner

Posts tagged as: PVCT back to homepage

FDA Gives Provectus Guidance for Phase 3 Cancer Research FDA Gives Provectus Guidance for Phase 3 Cancer Research(0)

Heading down the path in search of a Special Protocol Assessment (SPA) from the Food and Drug Administration, Provectus Pharmaceuticals (OTCBB:PVCT), a biotech specialized in developing oncology and dermatology therapies, has received guidance from the FDA to submit its Phase 3 protocol for review.  After several Read More

OTCBB News

Arthritis Foundation to Distribute Pacific Shore’s Thermal Aid Bears for Kids Arthritis Foundation to Distribute Pacific Shore’s Thermal Aid Bears for Kids(0)
Rarus Inks Deal for Social Media Augmented Reality Software Rarus Inks Deal for Social Media Augmented Reality Software(0)
West Point Places Order with Intergetics West Point Places Order with Intergetics(0)
CrowdGather: Capitalize on the Silent Majority CrowdGather: Capitalize on the Silent Majority(0)
GelTech Receives First Order for FireIce from Turkey GelTech Receives First Order for FireIce from Turkey(0)
Lyris to Host Third Quarter Earnings Webcast Lyris to Host Third Quarter Earnings Webcast(0)
read more


Stay Informed

Receive the OTCS Newsletter *




*

* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Gateways

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories
Disclaimer/Disclosure
© 2011 Viper Enterprises, LLC. All rights reserved.